Cardiac Abnormalities in Acromegaly Patients: A Cardiac Magnetic Resonance Study
Table 1
Clinical data and hormone levels of acromegaly patients.
Whole group (n = 61)
Male patients (n = 34)
Female patients (n = 27)
Age (year)
43.2 ± 13.3
40.6 ± 12.2
46.4 ± 14.0
Body mass index (kg/m2)
26.1 ± 3.8
27.5 ± 4.1
24.4 ± 2.6
Disease duration (month)
78.5 ± 57.0
82.4 ± 58.6
73.6 ± 55.7
GH (ng/ml)
36.3 ± 43.7
35.7 ± 44.0
42.6 ± 57.8
GH nadir (ng/ml)
28.2 ± 41.4
26.1 ± 35.3
30.8 ± 48.5
IGF-1 (ng/ml)
896.4 ± 253.9
978.9 ± 234.1
792.6 ± 243.0
Heart rate (beats/min)
78.1 ± 6.1
78.0 ± 6.7
78.2 ± 5.3
Systolic blood pressure (mmHg)
122.6 ± 11.6
121.4 ± 10.5
124.2 ± 12.9
Diastolic blood pressure (mmHg)
77.3 ± 8.9
78.8 ± 9.6
75.5 ± 7.8
Arterial hypertension (yes/no, %)
11/50, 18.0
9/25, 26.5
2/25, 7.4
Hyperlipemia (yes/no, %)
8/53, 13.1
5/29, 8.2
3/24, 4.9
Diabetes mellitus (yes/no, %)
8/53, 13.1
4/30, 6.6
4/23, 6.6
Smoking habit (yes/no, %)
12/49, 19.7
11/23, 32.4
1/26, 3.7
GH, growth hormone; IGF-1, insulin-like growth factor 1. Values are presented as frequencies (%) and the mean ± standard deviation. It means the difference between male and female patients is significant ().
